Close

Rating History for Halozyme Therapeutics (HALO) by Piper Sandler

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/7/2023 Joseph Catanzaro Maintain Overweight
(N/A)
46.00
(48.00)
 
 
  Details